Karin Flyborg

University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada.

New Mountain Capital LLC (New Mountain Capital) is a private equity firm founded in 1999 by Steven Klinsky. The firm is headquartered in New York.

Decam AB provides advertising services and business solutions. The private company is based in Karlskrona, Sweden and has subsidiaries in Sweden.

Rhodia Pharma Solutions Ltd. manufactures pharmaceutical products. The company was founded on August 26, 1965 and is headquartered in Watford, the United Kingdom.

ALMI Företagspartner AB provides financing and business development consulting services. Its task to be responsible for management, coordination, development of products and activities plus the servicing of group-wide functions of its subsidiaries. The company was founded in 1994 and is headquartered in Stockholm, Sweden.

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada.

Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du.

American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington.

GU Ventures AB (GU Ventures) is a venture capital subsidiary of University of Gothenburg founded in 1995. The firm is headquartered in Gothenburg, Sweden.

Connect Sverige Region Syd operates as a non-profit organization that offers financial advices and entrepreneurial support. The company was founded in 1999 and is headquartered in Lund, Sweden.

Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada.

Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada.

The Royal Society of Canada offers educational courses. The non-profit company is based in Ottawa, Canada. The CEO of the Canadian company is Iris Almeida-Cote.

Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland.

Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada.

Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Puridify Ltd. develops bioprocessing technologies. It develops a platform purification technology that will improve processing opportunities and reduce costs. The company was founded by Oliver Hardick, Iwan Thomas Roberts and Thomas Edward Haywood in 2013 and is headquartered in Stevenage, the United Kingdom.

The Ontario Institute For Regenerative Medicine provides stem cell and regenerative medicine research services. The company was founded by on November 25, 2014 and is headquartered in Toronto, Canada.

Part of Danaher Corp., Cytiva Sweden Holding AB provides investment and real estate services. The company is based in Uppsala, Sweden.

ExCellThera, Inc. is a world leader in blood stem cell expansion and rejuvenation. The private company is based in Montréal, Canada. The Canadian company's proprietary molecule, UM171, is the standard for hematopoietic stem cell expansion in cell and gene therapy. UM171 has a first-in-class mechanism of action that expands and rejuvenates HSCs, and counteracts exhaustion from culture and gene modification, which are important limitations in cell and gene therapies. ExCellThera has developed commercial GMP grade UM171, which can be integrated into the manufacturing process of various cell and gene therapy products as a reagent and is supported by a Type II Drug Master File (DMF) filed with the FDA. ExCellThera was founded in 2013 by Peter Zandstra and Guy Sauvageau. Guy Sauvageau has been the CEO since 2013.

Ascensus Specialties LLC provides specialty chemicals. Its products include alkali metals, boranes, borohydrides, boronic acid & esters, specialty and alcoholates. The firm serves life sciences and pulp & paper industries. The company was founded in 1946 and is headquartered in Bellevue, WA.

Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada.

Gamma Biosciences operates as a life sciences tools platform. It focuses on next-generation bioprocessing and technologies for the production of advanced therapies, such as gene and cell-based therapies. The company was founded in 2019 and is headquartered in Menlo Park, CA.

The Centre for the Commercialization of Antibodies & Biologics is a Canadian company that manufactures pharmaceutical products.

Part of Danaher Corp., Cytiva Bioscience Holding Ltd. is an investment holding British company. The company is based in Little Chalfont, UK.

Omniabio, Inc. is a subsidiary of CCRM and is a contract development and manufacturing organization producing gene-modified cells and viral vectors, compliant with current good manufacturing practices standards. The private company's facility, located at McMaster Innovation Park in Hamilton, Canada, will be the first commercial-scale CDMO dedicated to cell and gene therapies and is expected to be the largest facility of its kind. The company is based in Hamilton, Canada and is supported by the government of Ontario via the Invest Ontario Fund. Omniabio will anchor a biomanufacturing center of excellence and will open in three phases between 2024 and 2026. The CEO of the Canadian company is Mitchel Sivilotti.